CAS Index

StructureChemical NameCASMF
L-Proline, 3-hydroxy-4-methyl-, methyl ester, (2alpha,3beta,4beta)- (9CI) 104197-66-2 C7H13NO3
Silicic acid (H4SiO4), tetraethyl ester, hydrolysis products with 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane and hexamethyldisiloxane 104199-38-4 C22H56O6Si5
Naphthalenesulfonic acid, C6-9-alkyl Me derivs., sodium salts 104199-39-5
2-Propenoic acid, 2-methyl-, decyl ester, polymer with dodecyl 2-methyl-2-propenoate, hexadecyl 2-methyl-2-propenoate, hexyl 2-methyl-2-propenoate, methyl 2-methyl-2-propenoate, octadecyl 2-methyl-2-propenoate, octyl 2-methyl-2-propenoate and tetradecyl 2 104199-42-0 C117H218O16
2-Propenoic acid, 2-methyl-, decyl ester, polymer with dodecyl 2-methyl-2-propenoate, hexadecyl 2-methyl-2-propenoate, hexyl 2-methyl-2-propenoate, octadecyl 2-methyl-2-propenoate, octyl 2-methyl-2-propenoate and tetradecyl 2-methyl-2-propenoate 104199-43-1 C112H210O14
Ferrate(1-), 5-2,4-dihydroxy-5-(2-hydroxy-3,5-dinitrophenyl)azophenylazo-2-naphthalenesulfonato(3-)-, sodium 104199-50-0 C22H14FeN6NaO10S+
Ferrate(2-), 3-(hydroxy-.kappa.O)-4-2-(hydroxy-.kappa.O)-4-hydroxy-5-2-methyl-5-(methylsulfonyl)amino-4-4-(phenylamino)-3-sulfophenylazophenylazo-3-(phenylazo)phenylazo-.kappa.N1-7-nitro-1-naphthalenesulfonato(4-)-, sodium hydrogen 104199-51-1 C42H30FeN11NaO13S3
BOC-D-ASN-ONP 104199-82-8 C15H19N3O7
Le(y)-active trifucosylnonaosylceramide 104200-12-6
2-Propenoic acid, 3-(2-fluorophenyl)-, Methyl ester, (E)- 104201-65-2 C10H9FO2
(2E)-3-[3-(Trifluoromethyl)phenyl]-2-propenoic acid methyl ester 104201-66-3 C11H9F3O2
1-Bromo-3-phenylimidazo[1,5-a]pyridine 104202-15-5 C13H9BrN2
estriol 3,17-dipropionate 104202-88-2
estriol 3,17-dihexanoate 104202-96-2 C30H44O5
2(1H)-NAPHTHALENONE, 6-FLUORO-3,4-DIHYDRO-1-(1-METHYLETHYL)- 104204-91-3 C13H15FO
(S)-6-FLUORO-1-ISOPROPYL-3,4-DIHYDRO-1H-NAPHTHALEN-2-ONE 104205-01-8 C13H15FO
.beta.-D-Glucopyranose, 1,6-anhydro-2-deoxy-4-O-(phenylmethyl)-2-(2-propenyl)- 104206-19-1 C16H20O4
.beta.-D-Glucopyranose, 1,6-anhydro-2-chloro-2-deoxy-4-O-(phenylmethyl)- 104206-20-4 C13H15ClO4
2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione 104206-65-7 C14H10F3NO5
Mesotrione 104206-82-8 C14H13NO7S
5-CHLORO-4-ETHYL-2-HYDROXYBENZENESULFONIC ACID 104207-29-6 C8H9ClO4S
3,5-DICHLORO-4-ETHYL-2-HYDROXYBENZENESULFONIC ACID 104207-31-0 C8H8Cl2O4S
1,3-DIMETHYL-2-(2-THIENYL)IMIDAZOLIDINE 104208-13-1 C9H14N2S
1,3-DIMETHYL-2-(2-FURYL)IMIDAZOLIDINE 104208-14-2 C9H14N2O
1-hydroxy-24,24-dimethyl-22-dehydrovitamin D3 104211-64-5 C29H46O2
1,25-dihydroxy-24,24-dimethyl-22-dehydrovitamin D3 104211-73-6 C29H46O3
lithocholyl-N-hydroxysuccinimide 104211-94-1 C28H43NO5
N-carbobenzoxy-N-lithocholyl-epsilon-lysine 104211-96-3 C38H58N2O6
6,8-DIMETHYLFLAVONE 104213-91-4 C17H14O2
Finasteride Impurity 11 104214-18-8 C20H29NO3
Dutasteride Related Impurity 1 104214-61-1 C19H28N2O2
4,4'-DDT (13C12) 104215-84-1 C14H9Cl5
GAMMA-HCH 13C6 104215-85-2 C6H6Cl6
3-methoxy-2-propoxybenzoic acid 104215-92-1 C11H14O4
3-Ethyl-1,5-dimethyl-3,7-diaza-bicyclo[3.3.1]-nonan-9-ol 104215-93-2 C11H14O4
8-Quinolinamine,3-ethyl-(9CI) 104215-99-8 C11H12N2
BENZONITRILE, 2,6-DIETHYL-4-NITRO- 104216-34-4 C11H12N2O2
3-[(3,4-DIMETHYLPHENYL)THIO]PROPANOIC ACID 104216-46-8 C11H14O2S
(4-Methoxy-3,5-dimethylphenyl)acetic acid 104216-50-4 C11H14O3
4,6-DiMethyl-2-Methoxyphenylacetic acid 104216-51-5 C11H14O3
2-(4-METHOXY-2,5-DIMETHYLPHENYL)ACETIC ACID 104216-78-6 C11H14O3
1,3-Dioxane,5-methoxy-2-phenyl-(9CI) 104216-84-4 C11H14O3
5-Methyl-2-isopropoxybenzoic acid 104216-91-3 C11H14O3
2-hydroxy-5-phenylpentanoic acid(WXC05386) 104216-93-5 C11H14O3
(2,3,4-TRIMETHOXYPHENYL)ACETALDEHYDE 104216-97-9 C11H14O4
4-AMINO-6-METHOXY-2-METHYLQUINOLINE 104217-23-4 C11H12N2O
2-Quinoxalinemethanol,-alpha-,3-dimethyl-(6CI) 104217-24-5 C11H12N2O
2-(DiethoxyMethyl)-3-hydroxypyridine 104217-48-3 C10H15NO3
PTH (1-38) (HUMAN) 104218-12-4
2-Propenoic acid, 2-methyl-, decyl ester, polymer with dodecyl 2-methyl-2-propenoate, heptyl 2-methyl-2-propenoate, hexadecyl 2-methyl-2-propenoate, methyl 2-methyl-2-propenoate, nonyl 2-methyl-2-propenoate, octadecyl 2-methyl-2-propenoate, octyl 2-methyl 104218-13-5 C131H244O18
3''-O-MESYL-5''-O-TRITYLTHYMIDINE 104218-44-2 C30H30N2O7S
AMBERLITE XAD-16 104219-63-8
medosan 104220-24-8
omiderm 104220-30-6
phoB protein 104220-36-2
disialosyl Le(a) 104220-70-4
Thieno(3,4-d)isothiazol-3-amine, N-(phenylmethyl)-N-(3-(3-(1-piperidin ylmethyl)phenoxy)propyl)-, 1,1-dioxide 104221-86-5 C27H31N3O3S2
N-(8-QUINOLINYL)THIOUREA 104222-20-0 C10H9N3S
2,2'-AZOBIS[2-METHYL-N-[1,1-BIS(HYDROXYMETHYL)-2-HYDROXYETHYL]PROPIONAMIDE] 104222-32-4 C16H32N4O8
5-CHLORO-4-FLUORO-2-NITROANILINE 104222-34-6 C6H4ClFN2O2
3-Bromo-2,4,5-trifluorobenzonitrile 95% 104222-41-5 C7HBrF3N
3-Bromo-2,4,5-trifluorobenzoic acid 104222-42-6 C7H2BrF3O2
Ethyl 3-bromo-2,4,5-trifluorobenzoylacetate 104222-46-0 C11H8BrF3O3
3-FLUORO-3-PHENYL-AZETIDINE 104223-56-5 C9H10FN
Pyridine, 2,3,4-trimethyl-6-(1-methylethyl)- (9CI) 104223-90-7 C11H17N
Pyridine,3,4,6-trimethyl-2-(1-methylethyl)-(9CI) 104223-91-8 C11H17N
2-Hexanone, 4-methylene- (9CI) 104223-92-9 C7H12O
Pyridine, 4-ethyl-2-methyl-6-(1-methylethyl)- (9CI) 104223-97-4 C11H17N
5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-2-NAPHTHALENECARBONYL CHLORIDE 104224-50-2 C15H19ClO
3-(1-adamantyl)-4-methoxybenzoic acid 104224-62-6 C18H22O3
1-(5-Bromo-2-methoxy-phenyl)adamantane 104224-63-7 C17H21BrO
2-(1-Adamantyl)-4-bromophenol 104224-68-2 C16H19BrO
HC VIOLET NO. 2 104226-19-9 C13H21N3O5
HC YELLOW NO. 7 104226-21-3 C17H22N4O2
N-1-Benzyl-N-1-methyl-1,4-benzenediamine 104226-31-5 C14H16N2
Dimethyl-5-mehtoxycarbonyl-2-oxopentyl phosphonate, 98 % 104227-38-5 C9H17O6P
(S)-3-Boc-Amino-gamma-butyrolactone 104227-71-6 C9H15NO4
2-[2-(2-AMINO-9H-PURIN-9-YL)ETHYL]-1,3-PROPANEDIOL 104227-86-3 C10H15N5O2
Famciclovir 104227-87-4 C14H19N5O4
MONO-DESACETYL FAMCICLOVIR 104227-88-5 C12H17N5O3
9-[2-(2,2-Dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-amine 104227-89-6 C13H19N5O2
ETHYL4-(ACETYLTHIO)BUTYRATE 104228-51-5 C8H14O3S
N-Phenyl-3-hydroxy-4-(2-hydroxy-5-chlorophenylazo)naphthalene-2-carboxamide 104229-67-6
4-(4-(bis(2-chloroethyl)amino)phenyl)-1-hydroxybutane-1,1-bisphosphonic acid 104233-81-0
Butanoic acid, 2-[(chloroacetyl)amino]-2-ethyl- (9CI) 104234-94-8 C8H14ClNO3
N-formyl-methionylleucyl-phenylalanyl-N(epsilon)-(2-(4-azidosalicylamido)ethyl-1,3'-dithiopropionyl)lysine 104234-99-3
Cyclopentanecarboxaldehyde, 2-(dimethylamino)- (9CI) 104235-95-2 C8H15NO
Tartrazine Impurity 6 104236-33-1 C16H13N4NaO6S
Hexamidine EP Impurity A HCl 104236-65-9 C19H24ClN3O3
2',4'-DIHYDROXY-2-METHOXYCHALCONE 104236-78-4 C16H14O4
4-Aza-5a-androstan-1-ene-3-one-17b-carboxylic acid 104239-97-6 C19H27NO3
2-Butenedioic acid (2E)-, dibutyl ester, polymer with ethenylbenzene, 2-hydroxyethyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate 104242-04-8 C31H46O9
2-Propenoic acid, polymer with 1,3-benzenedimethanamine 104242-06-0 C11H16N2O2
Formaldehyde, polymer with 1,3-benzenedimethanamine, 4-(1,1-dimethylethyl)phenol, nonylphenol and C,C,C-trimethyl-1,6-hexanediamine 104242-08-2 C15H30O6
C.I. Solvent Yellow 162 104244-10-2
chounghwamycin A 104245-07-0 C7H9N5
anguibactin 104245-09-2 C15H16N4O4S
Medetomidine Impurity 3 104245-83-2 C10H13Cl
2-CHLORO-N-{4-[(1,3-THIAZOL-2-YLAMINO)SULFONYL]PHENYL}ACETAMIDE 104246-27-7 C11H10ClN3O3S2
2-CHLORO-N-{4-[(PYRIMIDIN-2-YLAMINO)SULFONYL]PHENYL}ACETAMIDE 104246-28-8 C12H11ClN4O3S
563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723